medmix AG(CH:MEDX)
CHFÂ 10.10-0.16 (-1.56%)
CH:MEDX
medmix AG financials statements
CHFÂ 10.10
At close:-0.16 (-1.56%)
Want to see CH:MEDX full AI Analyst Report?
medmix AG (MEDX) Ratios
1 Followers
medmix AG Ratios
CH:MEDX's free cash flow for Q2 2026 was CHF13.10M. For the 2026 fiscal year, CH:MEDX's free cash flow was decreased by CHF-8.80M and operating cash flow was CHF21.90M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.54 | 1.60 | 1.73 | 1.80 | 2.89 |
| Quick Ratio | 1.10 | 1.14 | 1.23 | 1.47 | 2.22 |
| Cash Ratio | 0.61 | 0.59 | 0.73 | 1.16 | 1.79 |
| Solvency Ratio | 0.11 | 0.11 | 0.10 | 0.10 | 0.22 |
| Operating Cash Flow Ratio | 0.39 | 0.53 | 0.31 | 0.18 | 0.74 |
| Short-Term Operating Cash Flow Coverage | 7.45 | 8.49 | 1.78 | 0.31 | 5.36 |
| Net Current Asset Value | CHF -271.20M | CHF -246.30M | CHF -224.30M | CHF -112.10M | CHF -100.80M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.34 | 0.35 | 0.43 | 0.33 |
| Debt-to-Equity Ratio | 0.78 | 0.74 | 0.75 | 0.94 | 0.60 |
| Debt-to-Capital Ratio | 0.44 | 0.43 | 0.43 | 0.48 | 0.38 |
| Long-Term Debt-to-Capital Ratio | 0.37 | 0.36 | 0.35 | 0.33 | 0.31 |
| Financial Leverage Ratio | 2.28 | 2.19 | 2.16 | 2.19 | 1.83 |
| Debt Service Coverage Ratio | 4.29 | 3.07 | 1.59 | 0.42 | 4.18 |
| Interest Coverage Ratio | 3.04 | 1.09 | 1.58 | 3.02 | 7.13 |
| Debt to Market Cap | 0.56 | 0.72 | 0.36 | 0.56 | 0.14 |
| Interest Debt Per Share | 8.32 | 8.22 | 8.80 | 11.72 | 8.01 |
| Net Debt to EBITDA | 2.82 | 3.36 | 3.20 | 2.34 | 1.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.14% | 33.00% | 32.41% | 36.76% | 39.62% |
| EBIT Margin | 6.12% | 1.18% | 2.67% | 3.92% | 13.05% |
| EBITDA Margin | 17.79% | 13.97% | 14.06% | 14.32% | 24.19% |
| Operating Profit Margin | 6.12% | 2.67% | 3.29% | 4.11% | 13.10% |
| Pretax Profit Margin | 2.01% | -1.30% | 0.60% | 2.56% | 11.22% |
| Net Profit Margin | 1.43% | -1.53% | 0.06% | 2.43% | 9.62% |
| Continuous Operations Profit Margin | 1.56% | -1.30% | 0.14% | 2.43% | 9.62% |
| Net Income Per EBT | 71.11% | 117.46% | 10.34% | 95.08% | 85.77% |
| EBT Per EBIT | 32.85% | -48.84% | 18.13% | 62.24% | 85.64% |
| Return on Assets (ROA) | 0.66% | -0.78% | 0.03% | 1.05% | 4.52% |
| Return on Equity (ROE) | 1.50% | -1.70% | 0.06% | 2.30% | 8.24% |
| Return on Capital Employed (ROCE) | 3.44% | 1.63% | 1.93% | 2.35% | 6.99% |
| Return on Invested Capital (ROIC) | 2.61% | 1.59% | 0.44% | 1.87% | 5.83% |
| Return on Tangible Assets | 1.07% | -1.31% | 0.05% | 1.59% | 7.58% |
| Earnings Yield | 1.40% | -2.06% | 0.04% | 1.61% | 2.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.54 | 10.34 | 8.38 | 7.70 | 15.19 |
| Payables Turnover | 6.65 | 8.23 | 6.66 | 6.36 | 6.72 |
| Inventory Turnover | 3.76 | 4.30 | 3.72 | 3.29 | 3.49 |
| Fixed Asset Turnover | 1.67 | 1.85 | 1.89 | 2.08 | 1.99 |
| Asset Turnover | 0.46 | 0.51 | 0.48 | 0.43 | 0.47 |
| Working Capital Turnover Ratio | 4.67 | 4.24 | 2.80 | 2.17 | 3.81 |
| Cash Conversion Cycle | 97.91 | 75.83 | 86.86 | 101.15 | 74.39 |
| Days of Sales Outstanding | 55.81 | 35.30 | 43.58 | 47.43 | 24.02 |
| Days of Inventory Outstanding | 96.96 | 84.89 | 98.10 | 111.06 | 104.70 |
| Days of Payables Outstanding | 54.86 | 44.36 | 54.82 | 57.35 | 54.33 |
| Operating Cycle | 152.77 | 120.19 | 141.68 | 158.49 | 128.73 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.66 | 2.12 | 1.37 | 1.16 | 2.12 |
| Free Cash Flow Per Share | 0.82 | 0.93 | 0.08 | 0.22 | 1.35 |
| Dividend Paid and CapEx Coverage Ratio | 1.37 | 1.36 | 0.83 | 0.89 | 1.19 |
| Capital Expenditure Coverage Ratio | 1.97 | 1.79 | 1.06 | 1.23 | 2.74 |
| Operating Cash Flow Coverage Ratio | 0.21 | 0.27 | 0.16 | 0.10 | 0.27 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.18 | 0.12 | 0.10 | 0.19 |
| Free Cash Flow Yield | 7.27% | 10.62% | 0.41% | 1.25% | 2.98% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 70.25 | -48.89 | 2588.33 | 62.14 | 42.20 |
| Price-to-Sales (P/S) Ratio | 1.02 | 0.74 | 1.60 | 1.51 | 4.06 |
| Price-to-Book (P/B) Ratio | 1.08 | 0.82 | 1.67 | 1.43 | 3.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.76 | 9.42 | 242.66 | 80.10 | 33.51 |
| Price-to-Operating Cash Flow Ratio | 6.76 | 4.14 | 13.84 | 15.14 | 21.27 |
| Price-to-Earnings Growth (PEG) Ratio | -0.37 | 0.02 | -26.58 | -0.84 | 0.12 |
| Enterprise Value Multiple | 8.57 | 8.67 | 14.56 | 12.90 | 17.79 |
| Enterprise Value | 683.10M | 586.06M | 995.60M | 880.86M | 1.97B |
| EV to EBITDA | 8.57 | 8.67 | 14.56 | 12.90 | 17.79 |
| EV to Sales | 1.52 | 1.21 | 2.05 | 1.85 | 4.30 |
| EV to Free Cash Flow | 20.51 | 15.38 | 311.13 | 97.87 | 35.52 |
| EV to Operating Cash Flow | 10.08 | 6.77 | 17.75 | 18.51 | 22.54 |
| Tangible Book Value Per Share | 1.54 | 1.42 | 1.94 | 3.17 | 3.41 |
| Shareholders’ Equity Per Share | 10.44 | 10.70 | 11.39 | 12.32 | 12.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.00 | 0.76 | 0.05 | 0.14 |
| Revenue Per Share | 10.99 | 11.87 | 11.91 | 11.65 | 11.12 |
| Net Income Per Share | 0.16 | -0.18 | 0.01 | 0.28 | 1.07 |
| Tax Burden | 0.71 | 1.17 | 0.10 | 0.95 | 0.86 |
| Interest Burden | 0.33 | -1.11 | 0.22 | 0.65 | 0.86 |
| Research & Development to Revenue | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 |
| SG&A to Revenue | 0.26 | 0.24 | 0.24 | 0.22 | 0.21 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Income Quality | 10.59 | -13.53 | 80.14 | 4.10 | 1.98 |
Currency in CHF

